featured
Efficacy and Safety of Dapagliflozin in People With HFrEF
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Dapagliflozin in Men and Women With Heart Failure With Reduced Ejection Fraction: A Prespecified Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure Trial
JAMA Cardiol 2021 Mar 31;[EPub Ahead of Print], JH Butt, KF Docherty, MC Petrie, M Schou, MN Kosiborod, E O'Meara, T Katova, CEA Ljungman, M Diez, MO Ogunniyi, AM Langkilde, M Sjöstrand, D Lindholm, O Bengtsson, FA Martinez, P Ponikowski, MS Sabatine, SD Solomon, PS Jhund, JJV McMurray, L KøberFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.